For allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, preemptive interferon-α (IFN-α) therapy is considered as a useful method to eliminate the minimal residual disease (MRD).
Supplementary Table from Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis
The survival risk ratios (SRRs) were calculated using linked hospitalisation and mortality data from New South Wales (NSW), Australia. Hospital admissions was obtained from the NSW Ministry of Health
This is data for our article"Beyond MRD: The Interplay Between Early T-Cell Subset Dynamics and Donor-Recipient Gender in Predicting Post-Transplantation Recurrence". This dataset provides de-identifi